APPLICATIONS / DATABASESSUPPLEMENTAL DATAFACULTYCOLLABORATIVE PROJECTSDEPARTMENTS
   
Section V
Previous Table of Contents Next

Table S17. Patient outcome data used in test set

Case Identifier

Studya

Relapseb

No Relapsec

inv16- #04

AML91

-

3402

inv16- #07

AML97

-

1474

MLL- #02

AML87

-

4036

MLL- #06

AML91

-

3092

MLL- #07

AML91

-

2720

MLL- #13

AML91

-

62

MLL- #15

AML97

-

1577

MLL- #20

AML91

223

-

MLL- #22

AML97

-

1565

Other- #01

AML87

0

-

Other- #09

AML87

595

-

Other- #14

AML91

642

-

Other- #17

AML91

182

-

Other- #22

AML91

-

2108

Other- #23

AML97

233

-

Other- #29

AML97

-

1592

Other- #30

AML97

0

-

Other- #32

AML97

-

157

Other- #34

AML87

0

-

Other- #37

AML97

268

-

Other- #39

AML97

324

-

Other- #42

AML97

-

381

Other-M7- #01

AML87

0

-

Other-M7-#07

AML91

0

-

t(8;21)- #02

AML87

425

-

t(8;21)- #05

AML87

0

-

t(8;21)- #07

AML97

-

14

t(8;21)- #10

AML97

291

-

t(8;21)- #19

AML97

-

891

t(8;21)- #20

AML87

340

-

a Treatment protocols: AML87, AML91, AML97 are St.Jude Children’s Research Hospital institutional protocols.
b Shown is the number of days from diagnosis to relapse.   “0” indicates that the patient never achieved a complete remission.
c Shown is the number of days from diagnosis to the last follow-up